SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-226456
Filing Date
2023-09-01
Accepted
2023-08-31 17:35:55
Documents
13
Period of Report
2023-08-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d538710d8k.htm   iXBRL 8-K 23575
2 EX-99.1 d538710dex991.htm EX-99.1 16149
  Complete submission text file 0001193125-23-226456.txt   164895

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA me-20230831.xsd EX-101.SCH 2843
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE me-20230831_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE me-20230831_pre.xml EX-101.PRE 10809
7 EXTRACTED XBRL INSTANCE DOCUMENT d538710d8k_htm.xml XML 3252
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 231229927
SIC: 2834 Pharmaceutical Preparations